Seven Harbour Global, LP 13F Filing History & Holdings
Seven Harbour Global, LP
CIK: 0001648946
Long-term holder
Total reported value
—
Reporting period: 2016-12-31 · Number of holdings: 1
Seven Harbour Global, LP disclosed 1 holdings in its latest 13F filing for the period ending 2016-12-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Recent moves
Unchanged 000000000
$0.0
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
✓
Ikena Oncology INC
Stock-Other
—
—
—
Portfolio Performance
Not enough priced holdings yet to compute performance
Position changes disclosed by Seven Harbour Global, LP for the quarter ending 2016-12-31, including ticker, issuer, weight change, shares change, and action
What is Seven Harbour Global, LP and what type of investor is it?
Seven Harbour Global, LP is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2016-12-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Seven Harbour Global, LP's largest equity positions?
Based on the latest 13F filing, Seven Harbour Global, LP's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Seven Harbour Global, LP make in its most recent portfolio filing?
No notable portfolio changes were recorded for Seven Harbour Global, LP in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Seven Harbour Global, LP focus on?
Sector breakdown data is not yet available for Seven Harbour Global, LP. Check back after the next 13F processing cycle.